carmustine has been researched along with Cancer of Lung in 112 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Considering the carcinogenesis model, we conclude that 2 or 4 weeks of N-nitroso-tris-chloroethylurea treatment may be suitable for investigating new chemicals for promotional or suppressive effects on lung squamous cell carcinoma." | 5.39 | Novel medium-term carcinogenesis model for lung squamous cell carcinoma induced by N-nitroso-tris-chloroethylurea in mice. ( Fujioka, M; Ishii, N; Kakehashi, A; Kitano, M; Tago, Y; Wanibuchi, H; Wei, M; Yamano, S, 2013) |
| "The combination of carmustine, cisplatin, dacarbazine, interferon, and low-dose tamoxifen is widely used in treating metastatic melanoma and was originally reported to achieve a 20% complete response rate." | 5.09 | Sustained complete remission after chemobiohormonal therapy for metastatic melanoma. ( Bernstein, Z; Drumea, K; Haim, N; Shklar, Z; Stein, ME; Steiner, M; Zalik, M, 1999) |
| "A selected case file of 32 patients with carcinoma of the lung which had passed the stage of surgical cure was randomized in 3 arms and treated with different schedules: regimen A, adriamycin plus cyclophosphamide; regimen B, the BACON combination, slightly modified; regimen CVP, cyclophosphamide plus vincristine plus prednisone." | 5.04 | Combined chemotherapy for unresectable carcinoma of the lung: a randomized trial. ( Arosio, A; Burdick, L; Cunietti, E; Eridani, S; Maggio, L; Periti, M; Perrone, G, 1978) |
| " The addition of a nitrosourea appears to be an improvement over cyclophosphamide used alone in oat cell carcinoma and over the two drug combination of cyclophosphamide and methotrexate in both adenocarcinoma of the lung and oat cell disease." | 5.04 | Nitrosourea combinations in lung cancer. ( Livingston, RB, 1976) |
| "Female Swiss mice (Cr:NIH(S)) developed bronchiolar cell hyperplasia, dysplasia, metaplasia, and various morphologic types of bronchiolar cell tumors after topical (skin) application of N-nitroso-methyl-bis-chloroethylurea (NMBCU) or N-nitroso-tris-chloroethylurea (NTCU)." | 3.68 | Mouse bronchiolar cell carcinogenesis. Histologic characterization and expression of Clara cell antigen in lesions induced by N-nitrosobis-(2-chloroethyl) ureas. ( Katyal, SL; Lijinsky, W; Rehm, S; Singh, G, 1991) |
| "A patient who had a pneumonectomy for lung carcinoma was treated with carmustine when brain metastases developed." | 3.66 | Pulmonary toxicity from carmustine (BCNU): a case report. ( Shah, S; Shane, SR; Weiss, RB, 1979) |
| "The therapeutic usefulness of chlorpromazine (CPZ) and caffeine (CAF) in combination with selected nitrosoureas was investigated in mice bearing L1210 leukemia, Lewis lung carcinoma, and B16 melanoma." | 3.66 | Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors. ( Dykes, DJ; Laster, WR; Rose, WC; Schabel, FM; Trader, MW, 1978) |
| "BCNU, hydroxyurea, and imidazole carboxamide (DTIC) were administered to 89 patients with disseminated malignant melanoma." | 3.65 | Combination chemotherapy for disseminated malignant melanoma. ( Coltman, CA; Costanzi, JJ; Delaney, FC; Hoogstraten, B; Quagliana, JM; Vaitkevicius, VK, 1975) |
| "Early phase evaluation of anticancer drugs has traditionally used toxicity (usually hematological) rather than efficacy end points to establish appropriate dosing schedules." | 2.69 | O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair. ( Gerson, SL; Haaga, J; Hoppel, CL; Ingalls, ST; Liu, L; Majka, S; Pluda, JM; Spiro, TP; Willson, JK, 1999) |
| "In small cell lung cancer initial high dose therapy followed by non-cross-resistant regimens may prove effective." | 2.37 | High dose chemotherapy in solid tumours in adults. ( Peters, W; Souhami, R, 1986) |
| "Diffuse pulmonary diseases seen in patients receiving chemotherapy have a wide variety of etiologies including infection, involvement with the underlying disease, injury from radiation or diagnostic agents, and toxicity from chemotherapeutic drugs." | 2.36 | Review: diagnosis of chemotherapy lung. ( Gamsu, G; Putman, CE; Sostman, HD, 1981) |
| "Lung cancer is the leading cause of cancer-related deaths, and squamous cell carcinoma (SCC) is one of the most common types of lung cancer." | 1.56 | Histopathological effect of pterostilbene as chemoprevention in N-nitroso-tri-chloroethylurea (NTCU)-induced lung squamous cell carcinoma (SCC) mouse model. ( Ghazali, AR; Masre, SF; Surien, O, 2020) |
| "Honokiol is an important bioactive compound found in the bark of Magnolia tree." | 1.40 | Honokiol inhibits lung tumorigenesis through inhibition of mitochondrial function. ( Kalyanaraman, B; Komas, SM; Liu, Q; Lubet, RA; Pan, J; Wang, Y; You, M; Zhang, Q, 2014) |
| "Considering the carcinogenesis model, we conclude that 2 or 4 weeks of N-nitroso-tris-chloroethylurea treatment may be suitable for investigating new chemicals for promotional or suppressive effects on lung squamous cell carcinoma." | 1.39 | Novel medium-term carcinogenesis model for lung squamous cell carcinoma induced by N-nitroso-tris-chloroethylurea in mice. ( Fujioka, M; Ishii, N; Kakehashi, A; Kitano, M; Tago, Y; Wanibuchi, H; Wei, M; Yamano, S, 2013) |
| " Currently, SU101 in combination with cytotoxic agents is in late-stage clinical development for the treatment of cancers." | 1.31 | Effects of SU101 in combination with cytotoxic agents on the growth of subcutaneous tumor xenografts. ( Cherrington, JM; Kabbinavar, F; Mann, E; Schwartz, DP; Shawver, LK; Slamon, DJ; Strawn, LM, 2000) |
| "Cyclocreatine was not very cytotoxic upon 24 h of exposure of human SW2 small-cell lung cancer cells to concentrations of up to 5 mM." | 1.29 | Cyclocreatine in cancer chemotherapy. ( Kaddurah-Daouk, R; Kufe, DW; Liu, J; Menon, K; Northey, D; Teicher, BA, 1995) |
| "The SF-767 brain tumors were extremely responsive to BE-4-4-4-4 alone (3 of 8 complete regressions after 2 cycles); however, the growth of the U-87 MG brain tumor was only slightly inhibited by BE-4-4-4-4 treatment." | 1.29 | Effect of 1,19-bis(ethylamino)-5,10,15-triazanonadecane on human tumor xenografts. ( Basu, HS; Casero, RA; Dolan, ME; Feuerstein, BG; Fleig, MJ; Luk, GD; Marton, LJ, 1994) |
| " In the dosage range of 600 to 1000 mg/m2 in heavily pretreated patients, BCNU is not recommended, but additional investigation may be warranted in patients with central nervous system metastases who previously were treated with radiation therapy." | 1.28 | High-dose carmustine and autologous bone marrow reinfusion in the treatment of refractory or relapsed small cell lung carcinoma. ( Baldauf, MC; Broste, S; Friedenberg, WR; Gehlsen, JA; Koontz, DP; Kriesel, DH; Rodvold, KA; Rushing, DA, 1991) |
| "Beneficial antitumor effects of low-dose chemotherapy (Adriamycin, BCNU, cisplatin, 5-fluorouracil, methotrexate, 6-thioguanine or vincristine) combined with an immunotherapy with a partially purified polysaccharide of Viva-Natural, an edible seaweed extract, have been demonstrated against intraperitoneally implanted Lewis lung carcinoma in syngeneic mice." | 1.28 | Antitumor potential of low-dose chemotherapy manifested in combination with immunotherapy of Viva-Natural, a dietary seaweed extract, on Lewis lung carcinoma. ( Furusawa, E; Furusawa, S, 1990) |
| " The collected experience emphasizes the many individual variables encountered in clinical practice complicating the effort of correlating pharmacokinetic data with clinical results." | 1.27 | Pharmacokinetic studies in lung cancer patients. ( Cattaneo, MT; Piazza, E; Varini, M, 1984) |
| "Metronidazole, 1." | 1.27 | Feasibility study of combining metronidazole with chemotherapy. ( Bélanger, R; Crook, AF; Heringer, R; Hopkins, HS; Hugenholtz, H; Maroun, JA; Richard, MT; Stewart, DJ; Yan, RC; Young, V, 1983) |
| "The mitomycin C and BCNU were alternated monthly at the start of each FUDR cycle." | 1.27 | Treatment of metastatic colorectal cancer with hepatic artery combination chemotherapy. ( Cohen, AM; Higgins, J; Schaeffer, N, 1986) |
| "Vitamin A, whether combined with various cytotoxic drugs or not, did not show, when different experimental schedules were used, an anti-tumour effect on various murine tumours." | 1.27 | Vitamin A: failure to demonstrate in mice an anti-tumour effect, whether combined with cytotoxic drugs or not. ( Bresson, ML; Cattan, A, 1986) |
| " However, the drug administered in combination with an antimetastatic, 1,2-bis(3,5-dioxopiperazin-1-yl)ethane (ICRF-154), resulted in an increase in survival time." | 1.27 | Intratumor chemotherapy in combination with a systemic antimetastatic drug in the treatment of Lewis-lung carcinoma. ( De-Oliveira, MM; Giannotti Filho, O; Joussef, AC; Nakamura, IT, 1985) |
| "Thirty-one patients with metastatic brain tumors (MBT) from lung cancer and ten patients with MBT from melanoma received BCNU, 100 mg/m2, every four weeks by intracarotid and/or vertebral artery infusion into each involved site." | 1.26 | Phase II study--intra-arterial BCNU therapy for metastatic brain tumors. ( Avellanosa, AM; Caracandas, J; Ghoorah, J; Jennings, E; Karakousis, C; Madajewicz, S; Park, HC; Takita, H; Vincent, R; West, CR, 1981) |
| "Experiments are described in which dose-response data have been obtained for EMT6 mouse tumour cells growing in vivo and exposed to various cytotoxic agents." | 1.26 | The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour. ( Bleehen, NM; Twentyman, PR, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 72 (64.29) | 18.7374 |
| 1990's | 26 (23.21) | 18.2507 |
| 2000's | 5 (4.46) | 29.6817 |
| 2010's | 6 (5.36) | 24.3611 |
| 2020's | 3 (2.68) | 2.80 |
| Authors | Studies |
|---|---|
| Montgomery, JA | 1 |
| McCaleb, GS | 1 |
| Johnston, TP | 2 |
| Mayo, JG | 2 |
| Laster, WR | 3 |
| Zakaria, MA | 1 |
| Rajab, NF | 1 |
| Chua, EW | 1 |
| Selvarajah, GT | 1 |
| Masre, SF | 2 |
| Böhlen, TT | 1 |
| Germond, JF | 1 |
| Traneus, E | 1 |
| Vallet, V | 1 |
| Desorgher, L | 1 |
| Ozsahin, EM | 1 |
| Bochud, F | 1 |
| Bourhis, J | 1 |
| Moeckli, R | 1 |
| Surien, O | 1 |
| Ghazali, AR | 1 |
| Riolobos, L | 1 |
| Gad, EA | 1 |
| Treuting, PM | 1 |
| Timms, AE | 1 |
| Hershberg, EA | 1 |
| Corulli, LR | 1 |
| Rodmaker, E | 1 |
| Disis, ML | 1 |
| Tago, Y | 2 |
| Yamano, S | 2 |
| Wei, M | 1 |
| Kakehashi, A | 1 |
| Kitano, M | 1 |
| Fujioka, M | 2 |
| Ishii, N | 2 |
| Wanibuchi, H | 2 |
| Pan, J | 2 |
| Zhang, Q | 1 |
| Liu, Q | 1 |
| Komas, SM | 1 |
| Kalyanaraman, B | 1 |
| Lubet, RA | 1 |
| Wang, Y | 2 |
| You, M | 1 |
| Song, JM | 1 |
| Qian, X | 1 |
| Teferi, F | 1 |
| Kassie, F | 1 |
| Ghosh, M | 1 |
| Dwyer-Nield, LD | 1 |
| Kwon, JB | 1 |
| Barthel, L | 1 |
| Janssen, WJ | 1 |
| Merrick, DT | 1 |
| Keith, RL | 1 |
| Gi, M | 1 |
| Doi, K | 1 |
| Okada, S | 1 |
| Hirayama, Y | 1 |
| Tachibana, H | 1 |
| Tatsumi, K | 1 |
| Ahmann, DL | 2 |
| Carr, DT | 1 |
| Coles, DT | 1 |
| Hahn, RG | 1 |
| FELTON, LR | 1 |
| Hua, XM | 1 |
| Ren, XW | 1 |
| Liu, FL | 1 |
| Liu, Y | 1 |
| Zhang, CJ | 1 |
| Li, ZJ | 1 |
| Xu, L | 1 |
| Liu, JY | 1 |
| Liu, YG | 1 |
| Sostman, HD | 1 |
| Putman, CE | 1 |
| Gamsu, G | 1 |
| Evans, RG | 1 |
| Burgert, EO | 1 |
| Gilchrist, GS | 1 |
| Smithson, WA | 1 |
| Pritchard, DJ | 1 |
| Bruckman, JE | 1 |
| Presant, CA | 2 |
| Hillinger, S | 1 |
| Klahr, C | 1 |
| Madajewicz, S | 1 |
| West, CR | 2 |
| Park, HC | 2 |
| Ghoorah, J | 2 |
| Avellanosa, AM | 1 |
| Takita, H | 2 |
| Karakousis, C | 1 |
| Vincent, R | 1 |
| Caracandas, J | 1 |
| Jennings, E | 1 |
| Hanna, MG | 1 |
| Key, ME | 1 |
| Carney, DN | 1 |
| Mitchell, JB | 1 |
| Kinsella, TJ | 1 |
| Stewart, P | 1 |
| Buckner, CD | 1 |
| Thomas, ED | 1 |
| Bagley, C | 1 |
| Bensinger, W | 1 |
| Clift, RA | 1 |
| Appelbaum, FR | 1 |
| Sanders, J | 1 |
| Piazza, E | 2 |
| Cattaneo, MT | 1 |
| Varini, M | 1 |
| Cornbleet, MA | 1 |
| Leonard, RC | 1 |
| Smyth, JF | 1 |
| Stewart, DJ | 1 |
| Maroun, JA | 1 |
| Young, V | 1 |
| Crook, AF | 1 |
| Hopkins, HS | 1 |
| Yan, RC | 1 |
| Richard, MT | 1 |
| Hugenholtz, H | 1 |
| Bélanger, R | 1 |
| Heringer, R | 1 |
| Klemm-Mayer, H | 1 |
| Rasokat, H | 1 |
| Wagner, G | 1 |
| Queisser, W | 1 |
| Schnitzler, G | 1 |
| Heim, ME | 1 |
| König, H | 1 |
| Katz, R | 1 |
| Fritze, D | 1 |
| Herrmann, R | 1 |
| Arnold, H | 1 |
| Henss, H | 1 |
| Trux, F | 1 |
| Rosso, R | 1 |
| Nobile, MT | 1 |
| Brema, F | 1 |
| Porcile, G | 1 |
| Cinquegrana, A | 1 |
| De Palma, M | 1 |
| Rubagotti, A | 1 |
| Weiss, RB | 2 |
| Issell, BF | 1 |
| Denes, AE | 1 |
| Bartolucci, A | 1 |
| Budzyński, W | 1 |
| Drago, JR | 1 |
| Worgul, TJ | 1 |
| Gallagher, C | 1 |
| Bertram, JS | 1 |
| Janik, P | 1 |
| Furusawa, E | 2 |
| Lockwood, RH | 1 |
| Eisenbrand, G | 1 |
| Habs, M | 1 |
| Ottolenghi, L | 1 |
| Morasca, L | 1 |
| Marsoni, S | 1 |
| Soresi, E | 1 |
| Libretti, A | 1 |
| Garattini, S | 1 |
| Greco, C | 1 |
| Calabresi, F | 1 |
| Corsi, A | 1 |
| Pericoli, N | 1 |
| Caputo, M | 1 |
| Dicke, KA | 1 |
| Hood, DL | 1 |
| Hanks, S | 1 |
| Vaughan, M | 1 |
| Fulbright, L | 1 |
| Dicke, JA | 1 |
| Arneson, M | 1 |
| Blumenschein, G | 1 |
| Teicher, BA | 2 |
| Menon, K | 1 |
| Northey, D | 1 |
| Liu, J | 1 |
| Kufe, DW | 1 |
| Kaddurah-Daouk, R | 1 |
| Saez, RA | 1 |
| Slease, RB | 1 |
| Selby, GB | 1 |
| Strnad, C | 1 |
| Epstein, RB | 2 |
| Confer, DL | 1 |
| Aabo, K | 2 |
| Vindeløv, LL | 3 |
| Christensen, IJ | 3 |
| Spang-Thomsen, M | 3 |
| Dolan, ME | 1 |
| Fleig, MJ | 1 |
| Feuerstein, BG | 1 |
| Basu, HS | 1 |
| Luk, GD | 1 |
| Casero, RA | 1 |
| Marton, LJ | 1 |
| Roed, H | 3 |
| Berhane, K | 1 |
| Hao, XY | 1 |
| Egyházi, S | 3 |
| Hansson, J | 3 |
| Ringborg, U | 3 |
| Mannervik, B | 2 |
| Gridelli, C | 1 |
| Perrone, F | 1 |
| D'Aprile, M | 1 |
| Rossi, A | 1 |
| Palmeri, S | 1 |
| Curcio, C | 1 |
| Veltri, E | 1 |
| Ianniello, G | 1 |
| Lorusso, V | 1 |
| Palmieri, G | 1 |
| Shaw, GL | 1 |
| Gazdar, AF | 1 |
| Phelps, R | 1 |
| Steinberg, SM | 1 |
| Linnoila, RI | 1 |
| Johnson, BE | 1 |
| Oie, HK | 1 |
| Russell, EK | 1 |
| Ghosh, BC | 1 |
| Pass, HI | 1 |
| Minna, JD | 1 |
| Mulshine, JL | 1 |
| Ihde, DC | 1 |
| Edgren, MR | 1 |
| Kröckel, D | 1 |
| Kakeji, Y | 1 |
| Bible, KC | 1 |
| Kaufmann, SH | 1 |
| de Crevoisier, R | 1 |
| le Cesne, A | 1 |
| le Chevalier, T | 2 |
| Stark, JJ | 1 |
| Dillman, RO | 1 |
| Schulof, R | 1 |
| Wiemann, MC | 1 |
| Barth, NM | 1 |
| Honeycutt, PJ | 1 |
| Soori, G | 1 |
| Stein, ME | 1 |
| Bernstein, Z | 1 |
| Drumea, K | 1 |
| Zalik, M | 1 |
| Shklar, Z | 1 |
| Steiner, M | 1 |
| Haim, N | 1 |
| Ophir, R | 1 |
| Moalem, G | 1 |
| Pecht, M | 1 |
| Shashoua, M | 1 |
| Rashid, G | 1 |
| Ben-Efraim, S | 1 |
| Trainin, N | 1 |
| Burstein, Y | 1 |
| Keisari, Y | 1 |
| Spiro, TP | 1 |
| Gerson, SL | 1 |
| Liu, L | 1 |
| Majka, S | 1 |
| Haaga, J | 1 |
| Hoppel, CL | 1 |
| Ingalls, ST | 1 |
| Pluda, JM | 1 |
| Willson, JK | 1 |
| Kiss, I | 1 |
| Tomasek, J | 1 |
| Strawn, LM | 1 |
| Kabbinavar, F | 1 |
| Schwartz, DP | 1 |
| Mann, E | 1 |
| Shawver, LK | 1 |
| Slamon, DJ | 1 |
| Cherrington, JM | 1 |
| Protheroe, AS | 1 |
| Pickard, C | 1 |
| Johnson, PW | 1 |
| Craddock, T | 1 |
| Shefta, J | 1 |
| Short, K | 1 |
| Lancaster, F | 1 |
| Selby, PJ | 1 |
| Henwood, J | 1 |
| Boylston, AW | 1 |
| Meloni, G | 1 |
| Proia, A | 1 |
| Guerrisi, V | 1 |
| Cordone, I | 1 |
| De Cuia, R | 1 |
| Fenu, S | 1 |
| Mauro, FR | 1 |
| Pescarmona, E | 1 |
| Reato, G | 1 |
| Mandelli, F | 1 |
| Alarcon, K | 1 |
| Demeunynck, M | 1 |
| Lhomme, J | 1 |
| Carrez, D | 1 |
| Croisy, A | 1 |
| Twentyman, PR | 3 |
| Bleehen, NM | 1 |
| Bruntsch, U | 1 |
| Eridani, S | 1 |
| Burdick, L | 1 |
| Maggio, L | 1 |
| Cunietti, E | 1 |
| Periti, M | 1 |
| Arosio, A | 1 |
| Perrone, G | 1 |
| Marmor, JB | 1 |
| Schabel, FM | 5 |
| Abeloff, MD | 2 |
| Ettinger, DS | 2 |
| Baylin, SB | 1 |
| Hazra, T | 1 |
| Livingston, RB | 1 |
| Khouri, NF | 1 |
| Lenhard, RE | 1 |
| Stylos, WA | 1 |
| Chirigos, MA | 2 |
| Lengel, CR | 1 |
| Shah, S | 1 |
| Shane, SR | 1 |
| Yamada, K | 1 |
| Bremer, AM | 1 |
| Smith, RH | 1 |
| Muren, O | 1 |
| Scott, RB | 1 |
| Frable, WJ | 1 |
| Rose, WC | 1 |
| Trader, MW | 1 |
| Dykes, DJ | 1 |
| Wolf, J | 1 |
| Hill, GJ | 1 |
| Johnson, RO | 1 |
| Metter, G | 1 |
| Wilson, WL | 1 |
| Davis, HL | 1 |
| Grage, T | 1 |
| Fletcher, WS | 1 |
| Golomb, FM | 1 |
| Cruz, AB | 1 |
| Stanley, JA | 1 |
| Shipley, WU | 1 |
| Steel, GG | 2 |
| Adams, K | 2 |
| Stanley, J | 1 |
| Wasserman, TH | 1 |
| Slavik, M | 1 |
| Carter, SK | 3 |
| Costanzi, JJ | 1 |
| Vaitkevicius, VK | 1 |
| Quagliana, JM | 1 |
| Hoogstraten, B | 2 |
| Coltman, CA | 2 |
| Delaney, FC | 2 |
| Mohr, SJ | 1 |
| Fuhrman, FS | 1 |
| Pryor, JW | 1 |
| Van Dyk, JJ | 1 |
| Falkson, G | 1 |
| Minn, H | 1 |
| Kangas, L | 1 |
| Kellokumpu-Lehtinen, P | 1 |
| Klemi, P | 1 |
| Sipilä, H | 1 |
| Vuorinen, J | 1 |
| Härkönen, P | 1 |
| Lähde, M | 1 |
| Jensen, PB | 1 |
| Sehested, M | 1 |
| Demant, EJ | 1 |
| Vindeløv, L | 1 |
| Hansen, HH | 2 |
| Rushing, DA | 1 |
| Friedenberg, WR | 1 |
| Baldauf, MC | 1 |
| Broste, S | 1 |
| Gehlsen, JA | 1 |
| Kriesel, DH | 1 |
| Koontz, DP | 1 |
| Rodvold, KA | 1 |
| Rehm, S | 1 |
| Lijinsky, W | 1 |
| Singh, G | 1 |
| Katyal, SL | 1 |
| Bergh, J | 1 |
| Karran, P | 1 |
| Ushio, Y | 1 |
| Arita, N | 1 |
| Hayakawa, T | 1 |
| Mogami, H | 1 |
| Hasegawa, H | 1 |
| Bitoh, S | 1 |
| Oku, Y | 1 |
| Ikeda, H | 1 |
| Kanai, N | 1 |
| Kanoh, M | 1 |
| O'Bryan, RM | 2 |
| Crowley, JJ | 1 |
| Kim, PN | 1 |
| Neilan, B | 1 |
| Stuckey, WJ | 1 |
| Pazdur, R | 1 |
| Furusawa, S | 1 |
| Cha, RJ | 1 |
| Pratesi, G | 1 |
| Savi, G | 1 |
| Pico, JL | 1 |
| Baume, D | 1 |
| Ostronoff, M | 1 |
| Beaujean, F | 1 |
| Gouyette, A | 1 |
| Arriagada, R | 1 |
| Rebattu, P | 1 |
| Hayat, M | 1 |
| Lange, OF | 1 |
| Souhami, R | 1 |
| Peters, W | 1 |
| Cohen, AM | 1 |
| Schaeffer, N | 1 |
| Higgins, J | 1 |
| Shea, TC | 1 |
| Antman, KH | 1 |
| Eder, JP | 1 |
| Elias, A | 1 |
| Peters, WP | 1 |
| Schryber, S | 1 |
| Henner, WD | 1 |
| Schoenfeld, DA | 1 |
| Schnipper, LE | 1 |
| Frei, E | 2 |
| Cattan, A | 1 |
| Bresson, ML | 1 |
| De-Oliveira, MM | 1 |
| Nakamura, IT | 1 |
| Joussef, AC | 1 |
| Giannotti Filho, O | 1 |
| Stephens, TC | 1 |
| Peacock, JH | 1 |
| Tofilon, PJ | 1 |
| Basic, I | 1 |
| Milas, L | 1 |
| Cohen, SM | 1 |
| Greenspan, EM | 1 |
| Weiner, MJ | 1 |
| Kabakow, B | 1 |
| Broder, LE | 1 |
| Lewis, MB | 1 |
| Nunes, LB | 1 |
| Powell, DE | 1 |
| Shnider, BI | 1 |
| Omura, GA | 1 |
| Roberts, GA | 1 |
| Gottlieb, JA | 2 |
| Rivkin, SE | 1 |
| Spigel, SC | 1 |
| Singhakowinta, A | 1 |
| Wheeler, GP | 1 |
| Alexander, JA | 1 |
| Einhorn, LH | 1 |
| Burgess, MA | 1 |
| Vallejos, C | 1 |
| Bodey, GP | 1 |
| Gutterman, J | 1 |
| Mavligit, G | 1 |
| Hersh, EM | 1 |
| Luce, JK | 1 |
| Freireich, EJ | 1 |
| Andrews, CM | 1 |
| Palma, J | 1 |
| Gailani, S | 1 |
| Freeman, A | 1 |
| Sinks, L | 1 |
| Holland, JF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase III Randomized Study of Hypofractionated vs Conventionally Fractionated Concurrent Chemo-radiotherapy for Limited Disease Small Cell Lung Cancer[NCT02688036] | Phase 3 | 860 participants (Anticipated) | Interventional | 2016-02-29 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 reviews available for carmustine and Cancer of Lung
| Article | Year |
|---|---|
Review: diagnosis of chemotherapy lung.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Bleomycin; Busulfan; Carmustine; Cy | 1981 |
High-dose alkylating agent therapy: a review of clinical experiences.
Topics: Alkylating Agents; Busulfan; Carcinoma, Bronchogenic; Carmustine; Dose-Response Relationship, Drug; | 1984 |
The nitrosoureas: carmustine (BCNU) and lomustine (CCNU).
Topics: Bone Marrow; Brain Neoplasms; Carmustine; Drug Therapy, Combination; Gastrointestinal Neoplasms; Hod | 1982 |
[Dose-effect of chemotherapy in bronchial small-cell cancer].
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineo | 1997 |
Interactions of hyperthermia and chemotherapy in animals.
Topics: Alkylating Agents; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bleomycin; Carmu | 1979 |
Rationale for adjuvant chemotherapy.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carmustine; Cyclophosphamide; Cytarabine; Doxorubi | 1977 |
Nitrosoureas: a review of experimental antitumor activity.
Topics: Animals; Carmustine; Colonic Neoplasms; Drug Evaluation, Preclinical; Drug Resistance; Drug Therapy, | 1976 |
Clinical comparison of the nitrosoureas.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Carmustine; Chemical Phenomena; C | 1975 |
High dose chemotherapy in solid tumours in adults.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marr | 1986 |
1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma; Carmustine; Cell Line; Cell-Free System; | 1972 |
17 trials available for carmustine and Cancer of Lung
| Article | Year |
|---|---|
Evaluation of cyclophosphamide (NSC-26271) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the treatment of patients with inoperable or disseminated lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carmustine; Cell Line, Tumo | 1972 |
[Comparision of high dose impulsion and low dose density chemotherapeutic regimens with paclitaxel plus cisplatin in advanced NSCLC].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Non-Small-C | 2004 |
[Prospective randomized study in advanced stomach cancer. Comparison between combinations of 5-fluorouracil and carmustine without and with adriamycin].
Topics: Adult; Aged; Carmustine; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Humans; Leukocyte Cou | 1984 |
Randomized trial of chemoimmunotherapy in advanced non-oat-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; BCG Vaccine; Carcinoma, Squamous Cell; Carmustine; Clinical Trials as T | 1982 |
Long-term survival after autologous bone marrow transplantation for metastatic breast carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; | 1995 |
Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Car | 1995 |
Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cel | 1996 |
Interferon-alpha and chemohormonal therapy for patients with advanced melanoma: final results of a phase I-II study of the Cancer Biotherapy Research Group and the Mid-Atlantic Oncology Program.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Da | 1998 |
Sustained complete remission after chemobiohormonal therapy for metastatic melanoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Dacarbazine; Female; Humans; | 1999 |
O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Biopsy; Biotransformation; Breast Neoplasms; Carmust | 1999 |
Combined chemotherapy for unresectable carcinoma of the lung: a randomized trial.
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Carcinoma; Carcinoma, Small Cell; Carmustine; Cycloph | 1978 |
Nitrosourea combinations in lung cancer.
Topics: Adenocarcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Carmustine; Clinical Trials as Topi | 1976 |
Nitrosoureas as single agents in the treatment of pulmonary cancer.
Topics: Carmustine; Clinical Trials as Topic; Cyclophosphamide; Female; Humans; Lomustine; Lung Neoplasms; M | 1976 |
Chemotherapy of brain metastases from lung carcinoma: a controlled randomized study.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma; Carcinom | 1991 |
Comparison of etoposide and cisplatin with bis-chloro-ethylnitrosourea, thiotepa, vincristine, and cyclophosphamide for salvage treatment in small cell lung cancer. A Southwest Oncology Group Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carmustine; Cisp | 1990 |
Triple combination chemotherapy of disseminated melanoma.
Topics: Aged; Alkylating Agents; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Drug Combinati | 1972 |
1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma; Carmustine; Cell Line; Cell-Free System; | 1972 |
86 other studies available for carmustine and Cancer of Lung
| Article | Year |
|---|---|
Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma.
Topics: Animals; Carcinoma; Leukemia L1210; Lung Neoplasms; Mice; Mice, Inbred Strains; Neoplasms, Experimen | 1977 |
NTCU induced pre-malignant and malignant stages of lung squamous cell carcinoma in mice model.
Topics: Animals; Biomarkers, Tumor; Carcinogens; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; C | 2021 |
3D-conformal very-high energy electron therapy as candidate modality for FLASH-RT: A treatment planning study for glioblastoma and lung cancer.
Topics: Carmustine; Electrons; Glioblastoma; Humans; Lung Neoplasms; Radiotherapy Dosage; Radiotherapy Plann | 2023 |
Histopathological effect of pterostilbene as chemoprevention in N-nitroso-tri-chloroethylurea (NTCU)-induced lung squamous cell carcinoma (SCC) mouse model.
Topics: Animals; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Carmustine; Disease Models, Animal; Fema | 2020 |
The Effect of Mouse Strain, Sex, and Carcinogen Dose on Toxicity and the Development of Lung Dysplasia and Squamous Cell Carcinomas in Mice.
Topics: Animals; Carcinogens; Carcinoma, Squamous Cell; Carmustine; Cell Transformation, Neoplastic; Dose-Re | 2019 |
Novel medium-term carcinogenesis model for lung squamous cell carcinoma induced by N-nitroso-tris-chloroethylurea in mice.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Carcinogenesis; Carcinoma, Squamous Cell; Carmustine; Cytoch | 2013 |
Honokiol inhibits lung tumorigenesis through inhibition of mitochondrial function.
Topics: Adenosine Triphosphate; Animals; Anticarcinogenic Agents; Apoptosis; Biphenyl Compounds; Bronchi; Ca | 2014 |
Dietary diindolylmethane suppresses inflammation-driven lung squamous cell carcinoma in mice.
Topics: Animals; Carcinoma, Squamous Cell; Carmustine; Cytokines; Diet; Disease Models, Animal; Female; Gene | 2015 |
Tracheal dysplasia precedes bronchial dysplasia in mouse model of N-nitroso trischloroethylurea induced squamous cell lung cancer.
Topics: Animals; Biomarkers, Tumor; Bronchi; Carcinoma, Squamous Cell; Carmustine; Cell Transformation, Neop | 2015 |
Role of deltaNp63(pos)CD44v(pos) cells in the development of N-nitroso-tris-chloroethylurea-induced peripheral-type mouse lung squamous cell carcinomas.
Topics: Animals; Carcinogens; Carcinoma, Squamous Cell; Carmustine; Disease Models, Animal; Disease Progress | 2016 |
Beam-directed high-dosage radiotherapy of bronchogenic carcinoma.
Topics: Carcinoma, Bronchogenic; Carmustine; Humans; Lung Neoplasms | 1952 |
Sequential half-body irradiation (SHBI) and combination chemotherapy as salvage treatment for failed Ewing's sarcoma--a pilot study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carmustine; Child; Fluor | 1984 |
Phase II study of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC No. 409962) with amphotericin B in bronchogenic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Amphotericin B; Bone Marrow; Carcinoma, Bronchogenic; Carcinoma, Small | 1980 |
Phase II study--intra-arterial BCNU therapy for metastatic brain tumors.
Topics: Adenocarcinoma; Adult; Aged; Brain Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Carmu | 1981 |
Immunotherapy of metastases enhances subsequent chemotherapy.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; BCG Vaccine; Carcinoma, Hepatocellular; Carmusti | 1982 |
In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variants.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Carmustine; Cell Line; Cell Survival; Dose-Response Re | 1983 |
Intensive chemoradiotherapy with autologous marrow transplantation for small cell carcinoma of the lung.
Topics: Autopsy; Bone Marrow Transplantation; Carcinoma, Small Cell; Carmustine; Combined Modality Therapy; | 1983 |
Pharmacokinetic studies in lung cancer patients.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carboplatin; Carmustine; Cisplatin; Cyclophospha | 1984 |
Feasibility study of combining metronidazole with chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma, Sq | 1983 |
[Marked regression of melanoma metastases under combined chemotherapy].
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Dacarbazine; Female | 1984 |
Combination chemotherapy for bronchogenic carcinoma with doxorubicin, BCNU, and cyclophosphamide (ABC): a pilot study of the Southeastern Cancer Study Group.
Topics: Adenocarcinoma; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Carmustine; Cyclophosphamide; Dox | 1982 |
Lewis lung carcinoma in mice as an experimental therapy model. II. The effect of BCNU, cyclophosphamide and/or surgery treatment on early and advanced tumor in mice.
Topics: Animals; Carmustine; Cyclophosphamide; Lung Neoplasms; Male; Mice; Mice, Inbred Strains; Neoplasm Tr | 1982 |
Castration--chemotherapy treatment of prostate cancer model.
Topics: Animals; Carmustine; Castration; Cell Transformation, Neoplastic; Cisplatin; Cyclophosphamide; Disea | 1981 |
Establishment of a cloned line of Lewis Lung Carcinoma cells adapted to cell culture.
Topics: Animals; Carmustine; Cell Line; Clone Cells; Graft Survival; Humans; Lung Neoplasms; Methotrexate; M | 1980 |
Therapeutic activity of pretazettine on Lewis lung carcinoma.
Topics: Alkaloids; Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents; Carmustine; Doxorubicin; Drug T | 1981 |
Chronic toxicity and carcinogenicity of cytostatic N-nitroso-(2-chloroethyl) ureas after repeated intravenous application to rats.
Topics: Animals; Antineoplastic Agents; Carcinogens; Carmustine; Lomustine; Lung Neoplasms; Male; Neoplasms, | 1980 |
Plasma levels of cyclophosphamide in patients under polychemotherapeutic regimens.
Topics: Adult; Carmustine; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Half-Life; Humans; Kine | 1980 |
Chemotherapeutic activity and histopathologic feature of BCNU + 5-FU effect on Lewis lung carcinoma.
Topics: Animals; Carmustine; Drug Therapy, Combination; Fluorouracil; Lung; Lung Neoplasms; Mice; Neoplasms, | 1980 |
A marrow harvest procedure under local anesthesia.
Topics: Anesthesia, Local; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marro | 1995 |
Cyclocreatine in cancer chemotherapy.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Small Cell; Carmustine; Cell Division; Ce | 1995 |
Low-dose chemotherapy delays relapse of a dominated and resistant sub-population in a heterogeneous human SCLC xenograft in nude mice.
Topics: Animals; Carcinoma, Small Cell; Carmustine; DNA, Neoplasm; Drug Resistance; Humans; Lung Neoplasms; | 1994 |
Effect of 1,19-bis(ethylamino)-5,10,15-triazanonadecane on human tumor xenografts.
Topics: Animals; Body Weight; Brain Neoplasms; Carmustine; Cell Division; Colonic Neoplasms; Drug Screening | 1994 |
A dominated and resistant subpopulation causes regrowth after response to 1,3-bis(2-chloroethyl)-1-nitrosourea treatment of a heterogeneous small cell lung cancer xenograft in nude mice.
Topics: Animals; Biopsy, Needle; Carcinoma, Small Cell; Carmustine; Cell Division; DNA, Neoplasm; Drug Resis | 1994 |
Contribution of glutathione transferase M3-3 to 1,3-bis(2-chloroethyl)-1-nitrosourea resistance in a human non-small cell lung cancer cell line.
Topics: Carcinoma, Non-Small-Cell Lung; Carmustine; DNA Repair; Drug Resistance; Enzyme-Linked Immunosorbent | 1993 |
Role of O6-methylguanine-DNA methyltransferase, glutathione transferase M3-3 and glutathione in resistance to carmustine in a human non-small cell lung cancer cell line.
Topics: Antineoplastic Agents, Alkylating; Carcinoma, Non-Small-Cell Lung; Carmustine; Dose-Response Relatio | 1997 |
Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Anti | 1997 |
Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carmustine; Cisplati | 1997 |
THF-gamma 2-mediated reduction of pulmonary metastases and augmentation of immunocompetence in C57BL/6 mice bearing B16-melanoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Female; Lung; Lung Neoplasms; L | 1999 |
Sodium and potassium excretion changes and bone marrow recovery after chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carcinoma, Small Cell; | 1999 |
Effects of SU101 in combination with cytotoxic agents on the growth of subcutaneous tumor xenografts.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cell Div | 2000 |
Persistence of clonal T-cell expansions following high-dose chemotherapy and autologous peripheral blood progenitor cell rescue.
Topics: Amino Acid Sequence; Antineoplastic Agents, Alkylating; Bone Marrow Purging; Breast Neoplasms; Carci | 2000 |
Acute myeloid leukemia and lung cancer occurring in a chronic lymphocytic leukemia patient treated with fludarabine and autologous peripheral blood stem-cell transplantation.
Topics: Acute Disease; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carm | 2000 |
Potentiation of BCNU cytotoxicity by molecules targeting abasic lesions in DNA.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; Carmustine; Cattle; DNA; Humans; Leukemi | 2001 |
The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour.
Topics: Animals; Antineoplastic Agents; Bleomycin; Carmustine; Cell Line; Cell Survival; Cyclophosphamide; D | 1976 |
[Chemotherapy in bronchogenic carcinoma (author's transl)].
Topics: Antineoplastic Agents; Bleomycin; Carcinoma, Bronchogenic; Carmustine; Cyclophosphamide; Doxorubicin | 1977 |
Comparative chemosensitivity of exponential- versus plateau-phase cells in both in vitro model systems.
Topics: Animals; Antineoplastic Agents; Bleomycin; Carmustine; Cell Division; Cell Survival; Cells, Cultured | 1976 |
Management of small cell carcinoma of the lung: therapy, staging, and biochemical markers.
Topics: Adult; Aged; Amine Oxidase (Copper-Containing); Carcinoma, Small Cell; Carmustine; Cyclophosphamide; | 1976 |
Intensive induction therapy for small cell carcinoma of the lung.
Topics: Aged; Antineoplastic Agents; Bone Marrow; Carcinoma, Small Cell; Carmustine; Cyclophosphamide; Doxor | 1979 |
Lymhocyte stimulatory effect of an ether-extracted preparation of Brucella abortus.
Topics: Animals; B-Lymphocytes; Brucella Vaccine; Carmustine; Lung Neoplasms; Lymphocyte Activation; Lymphoc | 1978 |
Pulmonary toxicity from carmustine (BCNU): a case report.
Topics: Autopsy; Brain Neoplasms; Carmustine; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasm Meta | 1979 |
Intra-arterial BCNU therapy in the treatment of metastatic brain tumor from lung carcinoma: a preliminary report.
Topics: Adult; Aged; Brain Neoplasms; Carmustine; Carotid Arteries; Female; Humans; Infusions, Intra-Arteria | 1979 |
Transbronchial brush biopsy: anti-mortem diagnosis of pulmonary infiltrates in non-Hodgkin's lymphoma.
Topics: Adult; Aged; Bronchi; Bronchoscopy; Carmustine; Doxorubicin; Humans; Lung Neoplasms; Lymphoma; Male | 1978 |
Sensitivity to 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea of the EMT6 tumor in vivo as determined by both tumor volume response and in vitro plating assay.
Topics: Animals; Carmustine; Cell Count; Cell Cycle; Cell Survival; Clone Cells; Lung Neoplasms; Male; Mamma | 1978 |
Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors.
Topics: Animals; Caffeine; Carmustine; Chlorpromazine; Drug Synergism; Drug Therapy, Combination; Female; Le | 1978 |
Multimodal surgical adjuvant therapy for a broad spectrum of tumors in humans.?
Topics: Adult; Altretamine; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carmustine; Colonic Neo | 1976 |
Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour.
Topics: Animals; Carmustine; Cell Survival; Cyclophosphamide; Dose-Response Relationship, Radiation; Gamma R | 1977 |
Size dependence of the response of Lewis lung tumors to BCNU.
Topics: Animals; Carmustine; Cell Survival; Clone Cells; In Vitro Techniques; Lung Neoplasms; Mice; Mice, In | 1976 |
Combination chemotherapy for disseminated malignant melanoma.
Topics: Adolescent; Adult; Aged; Amides; Antineoplastic Agents; Brain Neoplasms; Carmustine; Drug Therapy, C | 1975 |
Pyran copolymer as an effective adjuvant to chemotherapy against a murine leukemia and solid tumor.
Topics: Adjuvants, Immunologic; Animals; Carmustine; Leukemia, Experimental; Lung Neoplasms; Mice; Mice, Inb | 1975 |
A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma.
Topics: Adult; Aged; Carmustine; Dacarbazine; Drug Therapy, Combination; Female; Humans; Liver Neoplasms; Lu | 1975 |
Uptake of 2-fluoro-2-deoxy-D-[U-14C]-glucose during chemotherapy in murine Lewis lung tumor.
Topics: Adenosine Triphosphate; Animals; Carmustine; Deoxyglucose; Doxorubicin; Female; Flow Cytometry; Fluo | 1992 |
Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivity.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cel | 1992 |
High-dose carmustine and autologous bone marrow reinfusion in the treatment of refractory or relapsed small cell lung carcinoma.
Topics: Adult; Aged; Bone Marrow Transplantation; Carcinoma, Small Cell; Carmustine; Combined Modality Thera | 1991 |
Mouse bronchiolar cell carcinogenesis. Histologic characterization and expression of Clara cell antigen in lesions induced by N-nitrosobis-(2-chloroethyl) ureas.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Animals; Carcinoma, Squamous Cell; Carmustine; Female; Immunohi | 1991 |
Carmustine-induced toxicity, DNA crosslinking and O6-methylguanine-DNA methyltransferase activity in two human lung cancer cell lines.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carmustine; Cell Line; Cell Survival; DNA, Ne | 1991 |
Antitumor potential of low-dose chemotherapy manifested in combination with immunotherapy of Viva-Natural, a dietary seaweed extract, on Lewis lung carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carmustine; Doxorubicin; Immunotherapy; Lung Neoplasms; | 1990 |
[Combined modality treatment of small cell lung cancer by chemotherapy, radiotherapy, immunotherapy and Chinese traditional medicine].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carmustine; Comb | 1989 |
Effects of tauromustine, a water-soluble nitrosourea compound on NMU-1 murine lung tumor.
Topics: Animals; Carmustine; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Nitrosourea Compounds; Taurine | 1989 |
[High-doses chemotherapy followed by bone marrow autograft in the treatment of small cell bronchial cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carcinoma, Small Cell; | 1987 |
Concurrent chemo-radiotherapy in small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Small Cell; Carmustine; Combined Modality Therapy; Female; Humans; Ifosfamid | 1988 |
In vitro evaluation of a new nitrosourea, TCNU, against human small cell lung cancer cell lines.
Topics: Carcinoma, Small Cell; Carmustine; Cell Cycle; Cell Line; Colony-Forming Units Assay; Drug Evaluatio | 1987 |
Treatment of metastatic colorectal cancer with hepatic artery combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Colonic Neoplasms; Fluorouracil; Follow- | 1986 |
Malignant melanoma. Treatment with high-dose combination alkylating agent chemotherapy and autologous bone marrow support.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cisp | 1988 |
Vitamin A: failure to demonstrate in mice an anti-tumour effect, whether combined with cytotoxic drugs or not.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cyclophosphamide; Et | 1986 |
Intratumor chemotherapy in combination with a systemic antimetastatic drug in the treatment of Lewis-lung carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chromans; Injections; Lung Neop | 1985 |
Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo.
Topics: Animals; Carmustine; Cell Line; Cell Survival; Cisplatin; Cyclophosphamide; Dose-Response Relationsh | 1986 |
Prediction of in vivo tumor response to chemotherapeutic agents by the in vitro sister chromatid exchange assay.
Topics: Animals; Carmustine; Cell Survival; Cisplatin; Colony-Forming Units Assay; Liver Neoplasms, Experime | 1985 |
New drugs on the horizon in bronchogenic carcinoma.
Topics: Amines; Animals; Antineoplastic Agents; Azacitidine; Bleomycin; Carcinoma, Bronchogenic; Carmustine; | 1972 |
Extra-axial spread of medulloblastoma.
Topics: Autopsy; Brain Neoplasms; Carmustine; Cranial Fossa, Posterior; Femoral Neoplasms; Humans; Liver Neo | 1973 |
Combination therapy of solid tumors using 1,3-bis(2-chloroethyl)-1-nitrosourea (NCNU), vincristine, methotrexate, and 5-fluorouracil.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Carmustine; Female; Fluorouracil; Gastrointes | 1973 |
Proceedings: Superiority of adriamycin over oral nitrosoureas in patients with advanced breast carcinoma. A Southwest Cancer Chemotherapy study Group study.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Carmustine; Cyclohexanes; Doxorubicin; Female; Humans | 1974 |
Duration of inhibition of synthesis of DNA in tumors and host tissues after single doses of nitrosoureas.
Topics: Animals; Bone Marrow; Brain; Carmustine; Cricetinae; Cyclohexanes; Depression, Chemical; DNA, Neopla | 1974 |
Prognostic correlations and response to treatment in advanced metastatic malignant melanoma.
Topics: Adolescent; Adult; Aged; Amides; Antineoplastic Agents; Brain; Brain Neoplasms; Carmustine; Dexameth | 1974 |
Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy.
Topics: Animals; Antineoplastic Agents; Carcinoma; Carmustine; Cell Line; Cyclohexanes; Cyclophosphamide; Lu | 1972 |
The phase II study: some reflections, particularly concerning disseminated breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Carmustine; Cyclohexanes; Cyclophosphamide; Female; Fluorou | 1972 |
Treatment of metastatic Ewing's sarcoma with BCNU.
Topics: Adolescent; Adult; Bone Neoplasms; Carmustine; Child; Child, Preschool; Female; Humans; Injections, | 1972 |